These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 33220249)

  • 1. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.
    Ji D; Zhang M; Qin E; Zhang L; Xu J; Wang Y; Cheng G; Wang F; Lau G
    Metabolism; 2021 Feb; 115():154437. PubMed ID: 33220249
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
    Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
    Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT; Kleiner DE
    Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome.
    Kawada T
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2435. PubMed ID: 36372370
    [No Abstract]   [Full Text] [Related]  

  • 9. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
    Santos RD; Valenti L; Romeo S
    Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
    Angelico F; Del Ben M; Conti R; Francioso S; Feole K; Maccioni D; Antonini TM; Alessandri C
    J Gastroenterol Hepatol; 2003 May; 18(5):588-94. PubMed ID: 12702052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms behind the link between obesity and gastrointestinal cancers.
    Tilg H; Moschen AR
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management.
    Polyzos SA; Mantzoros CS
    Metabolism; 2024 Aug; 157():155936. PubMed ID: 38763229
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
    Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
    Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk.
    Zarzavadjian Le Bian A; Costi R; Constantinides V; Smadja C
    J Gastrointest Surg; 2012 Dec; 16(12):2247-55. PubMed ID: 23054903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
    Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
    Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis.
    Wang Y; Wang Y; Duan G; Yang H
    J Hepatol; 2023 Apr; 78(4):e136-e139. PubMed ID: 36309129
    [No Abstract]   [Full Text] [Related]  

  • 18. When the liver gets fatty. As Americans have gotten fatter, so have their livers, and some hearts may suffer as a result.
    Harv Health Lett; 2011 Jan; 36(3):4-5. PubMed ID: 21341411
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.